Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.

Tennstedt P, Köster P, Brüchmann A, Mirlacher M, Haese A, Steuber T, Sauter G, Huland H, Graefen M, Schlomm T, Minner S, Simon R.

Int J Oncol. 2012 Jan;40(1):261-8. doi: 10.3892/ijo.2011.1216. Epub 2011 Sep 28.

PMID:
21956230
[PubMed - indexed for MEDLINE]
2.

Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population.

Inoue T, Segawa T, Shiraishi T, Yoshida T, Toda Y, Yamada T, Kinukawa N, Kinoshita H, Kamoto T, Ogawa O.

Urology. 2005 Aug;66(2):332-7.

PMID:
16098362
[PubMed - indexed for MEDLINE]
3.

Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.

Zellweger T, Günther S, Zlobec I, Savic S, Sauter G, Moch H, Mattarelli G, Eichenberger T, Curschellas E, Rüfenacht H, Bachmann A, Gasser TC, Mihatsch MJ, Bubendorf L.

Int J Cancer. 2009 May 1;124(9):2116-23. doi: 10.1002/ijc.24174.

PMID:
19117060
[PubMed - indexed for MEDLINE]
4.

Tissue microarray sampling strategy for prostate cancer biomarker analysis.

Rubin MA, Dunn R, Strawderman M, Pienta KJ.

Am J Surg Pathol. 2002 Mar;26(3):312-9.

PMID:
11859202
[PubMed - indexed for MEDLINE]
5.

Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.

Stapleton AM, Zbell P, Kattan MW, Yang G, Wheeler TM, Scardino PT, Thompson TC.

Cancer. 1998 Jan 1;82(1):168-75.

PMID:
9428494
[PubMed - indexed for MEDLINE]
6.

Inactivation of the p53 pathway in prostate cancer: impact on tumor progression.

Osman I, Drobnjak M, Fazzari M, Ferrara J, Scher HI, Cordon-Cardo C.

Clin Cancer Res. 1999 Aug;5(8):2082-8.

PMID:
10473090
[PubMed - indexed for MEDLINE]
Free Article
7.

Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer.

Zellweger T, Ninck C, Mirlacher M, Annefeld M, Glass AG, Gasser TC, Mihatsch MJ, Gelmann EP, Bubendorf L.

Prostate. 2003 Apr 1;55(1):20-9.

PMID:
12640657
[PubMed - indexed for MEDLINE]
8.

p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy.

Cheng L, Sebo TJ, Cheville JC, Pisansky TM, Slezak J, Bergstralh EJ, Pacelli A, Neumann RM, Zincke H, Bostwick DG.

Cancer. 1999 Mar 15;85(6):1293-9.

PMID:
10189134
[PubMed - indexed for MEDLINE]
9.

Frequency of Ki-67 (MIB-1) and P53 expressions among patients with prostate cancer.

Madani SH, Ameli S, Khazaei S, Kanani M, Izadi B.

Indian J Pathol Microbiol. 2011 Oct-Dec;54(4):688-91. doi: 10.4103/0377-4929.91492.

PMID:
22234091
[PubMed - indexed for MEDLINE]
Free Article
10.

Percentage of positive biopsy cores as predictor of clinical outcome in prostate cancer treated with radiotherapy.

Kestin LL, Goldstein NS, Vicini FA, Martinez AA.

J Urol. 2002 Nov;168(5):1994-9.

PMID:
12394693
[PubMed - indexed for MEDLINE]
11.

Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy.

Cowen D, Troncoso P, Khoo VS, Zagars GK, von Eschenbach AC, Meistrich ML, Pollack A.

Clin Cancer Res. 2002 May;8(5):1148-54.

PMID:
12006531
[PubMed - indexed for MEDLINE]
Free Article
12.

Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.

Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Di Carlo L, Semeraro A, Daddi G, Darwish S, Stocchi L, Tofanetti FR, Bellezza G, Sidoni A, Tognellini R, Crinò L, Tonato M.

Tumori. 2008 May-Jun;94(3):398-405.

PMID:
18705409
[PubMed - indexed for MEDLINE]
13.

Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression.

Grossfeld GD, Carroll PR, Lindeman N, Meng M, Groshen S, Feng AC, Hawes D, Cote RJ.

Urology. 2002 Jan;59(1):97-102.

PMID:
11796289
[PubMed - indexed for MEDLINE]
14.

Prognostic significance of Bcl-2 in clinically localized prostate cancer.

Bubendorf L, Sauter G, Moch H, Jordan P, Blöchlinger A, Gasser TC, Mihatsch MJ.

Am J Pathol. 1996 May;148(5):1557-65.

PMID:
8623924
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Clinical significance of p53 alterations in surgically treated prostate cancers.

Schlomm T, Iwers L, Kirstein P, Jessen B, Köllermann J, Minner S, Passow-Drolet A, Mirlacher M, Milde-Langosch K, Graefen M, Haese A, Steuber T, Simon R, Huland H, Sauter G, Erbersdobler A.

Mod Pathol. 2008 Nov;21(11):1371-8. doi: 10.1038/modpathol.2008.104. Epub 2008 Jun 13.

PMID:
18552821
[PubMed - indexed for MEDLINE]
Free Article
16.

Prognostic factors in prostate cancer.

Stattin P.

Scand J Urol Nephrol Suppl. 1997;185:1-46.

PMID:
9249905
[PubMed - indexed for MEDLINE]
17.

p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting.

Borre M, Stausbol-Gron B, Overgaard J.

J Urol. 2000 Sep;164(3 Pt 1):716-21.

PMID:
10953132
[PubMed - indexed for MEDLINE]
18.

Parallel determination of NeuroD1, chromogranin-A, KI67 and androgen receptor expression in surgically treated prostate cancers.

Cindolo L, Cantile M, Franco R, Chiodini P, Schiavo G, Forte I, Zlobec I, Salzano L, Botti G, Gidaro S, Terracciano L, Cillo C.

Int Braz J Urol. 2011 Jan-Feb;37(1):57-66.

PMID:
21385481
[PubMed - indexed for MEDLINE]
Free Article
19.

Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.

Moul JW, Bettencourt MC, Sesterhenn IA, Mostofi FK, McLeod DG, Srivastava S, Bauer JJ.

Surgery. 1996 Aug;120(2):159-66; discussion 166-7.

PMID:
8751578
[PubMed - indexed for MEDLINE]
20.

An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer.

Uzoaru I, Rubenstein M, Mirochnik Y, Slobodskoy L, Shaw M, Guinan P.

J Surg Oncol. 1998 Jan;67(1):33-7. Review.

PMID:
9457254
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk